155 related articles for article (PubMed ID: 24072183)
1. ERG and FLI1 protein expression in epithelioid sarcoma.
Stockman DL; Hornick JL; Deavers MT; Lev DC; Lazar AJ; Wang WL
Mod Pathol; 2014 Apr; 27(4):496-501. PubMed ID: 24072183
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
3. Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma.
Wang WL; Patel NR; Caragea M; Hogendoorn PC; López-Terrada D; Hornick JL; Lazar AJ
Mod Pathol; 2012 Oct; 25(10):1378-83. PubMed ID: 22766791
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.
Tomlins SA; Palanisamy N; Brenner JC; Stall JN; Siddiqui J; Thomas DG; Lucas DR; Chinnaiyan AM; Kunju LP
Am J Clin Pathol; 2013 Jun; 139(6):771-9. PubMed ID: 23690120
[TBL] [Abstract][Full Text] [Related]
5. A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expression.
Tajima S; Takahasi Y; Hikoaki M; Goto R
Int J Clin Exp Pathol; 2015; 8(6):7526-32. PubMed ID: 26261664
[TBL] [Abstract][Full Text] [Related]
6. ERG expression in epithelioid sarcoma: a diagnostic pitfall.
Miettinen M; Wang Z; Sarlomo-Rikala M; Abdullaev Z; Pack SD; Fetsch JF
Am J Surg Pathol; 2013 Oct; 37(10):1580-5. PubMed ID: 23774169
[TBL] [Abstract][Full Text] [Related]
7. Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related Kaposi sarcoma.
Rosado FG; Itani DM; Coffin CM; Cates JM
Arch Pathol Lab Med; 2012 Mar; 136(3):301-4. PubMed ID: 22372906
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of ERG, Fli-1, CD34, CD31 and FⅧRAg expression in hepatic malignant vascular tumors].
Wang ZB; An XJ; Deng JF; Liu JH; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):760-763. PubMed ID: 29136688
[No Abstract] [Full Text] [Related]
9. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
[TBL] [Abstract][Full Text] [Related]
10. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases.
Sullivan HC; Edgar MA; Cohen C; Kovach CK; HooKim K; Reid MD
J Clin Pathol; 2015 Jan; 68(1):44-50. PubMed ID: 25352641
[TBL] [Abstract][Full Text] [Related]
11. CD31 immunohistochemical staining in Kaposi Sarcoma.
Pantanowitz L; Moses AV; Früh K
Arch Pathol Lab Med; 2012 Nov; 136(11):1329; author reply 1330. PubMed ID: 23106575
[No Abstract] [Full Text] [Related]
12. Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection.
Machado I; Mayordomo-Aranda E; Scotlandi K; Picci P; Llombart-Bosch A
Pathol Res Pract; 2014 Aug; 210(8):508-13. PubMed ID: 24906228
[TBL] [Abstract][Full Text] [Related]
13. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody.
Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP
Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993
[TBL] [Abstract][Full Text] [Related]
14. ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.
Tajima S; Takashi Y; Ito N; Fukumoto S; Fukuyama M
Med Mol Morphol; 2016 Dec; 49(4):203-209. PubMed ID: 26122367
[TBL] [Abstract][Full Text] [Related]
15. Angiosarcoma: a tissue microarray study with diagnostic implications.
Rao P; Lahat G; Arnold C; Gavino AC; Lahat S; Hornick JL; Lev D; Lazar AJ
Am J Dermatopathol; 2013 Jun; 35(4):432-7. PubMed ID: 23689692
[TBL] [Abstract][Full Text] [Related]
16. Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies.
Alikhan MB; Pease G; Watkin W; Grogan R; Krausz T; Antic T
Hum Pathol; 2017 Mar; 61():158-163. PubMed ID: 27769872
[TBL] [Abstract][Full Text] [Related]
17. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.
Miettinen M; Wang ZF; Paetau A; Tan SH; Dobi A; Srivastava S; Sesterhenn I
Am J Surg Pathol; 2011 Mar; 35(3):432-41. PubMed ID: 21317715
[TBL] [Abstract][Full Text] [Related]
18. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
19. ERG expression in chondrogenic bone and soft tissue tumours.
Shon W; Folpe AL; Fritchie KJ
J Clin Pathol; 2015 Feb; 68(2):125-9. PubMed ID: 25378537
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
Doyle LA; Fletcher CD; Hornick JL
Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
